Evidence map›Paper›PMID 42173910›Full record

ArticleScientific reports2026

Mast cell-driven remodeling of pulmonary immune and stromal landscapes in COVID-19.

D A Atiakshin, O A Burgasova, A A Kostin, A V Alekhnovich, A T Prikhodko, V A Galieva, M A Ignatyuk, M M Mirolaev, I D Klabukov, D S Baranovskii and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

D A AtiakshinRUDN University, 6 Miklukho-Maklaya St, Moscow, Russia, 117198. atyakshin-da@rudn.ru.
O A BurgasovaRUDN University, 6 Miklukho-Maklaya St, Moscow, Russia, 117198.
A A KostinRUDN University, 6 Miklukho-Maklaya St, Moscow, Russia, 117198.
A V AlekhnovichRUDN University, 6 Miklukho-Maklaya St, Moscow, Russia, 117198.
A T PrikhodkoRUDN University, 6 Miklukho-Maklaya St, Moscow, Russia, 117198.
V A GalievaRUDN University, 6 Miklukho-Maklaya St, Moscow, Russia, 117198.
M A IgnatyukRUDN University, 6 Miklukho-Maklaya St, Moscow, Russia, 117198.
M M MirolaevThe National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 18 Gamaleya St., Moscow, Russia, 123098.
I D KlabukovDepartment of Regenerative Medicine, National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Koroleva St. 4, Obninsk, Russia, 249036.
D S BaranovskiiDepartment of Regenerative Medicine, National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Koroleva St. 4, Obninsk, Russia, 249036.
M V TaranovaFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, 8 Trubetskaya Str., building 2, Moscow, Russia, 119048.
D Elieh-Ali-KomiInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
I BuchwalowRUDN University, 6 Miklukho-Maklaya St, Moscow, Russia, 117198.
M TiemannInstitute for Hematopathology, Fangdieckstr. 75a, 22547, Hamburg, Germany.

Funding

Ministry of Science and Higher Education of the Russian Federation FSSF-2023-0046
6 · The paper itself

Abstract

The role of mast cells (MCs) in the pathogenesis of COVID-19 remains poorly understood. In the present study, we profiled the spatial phenotype of MC interaction with the pulmonary immune and stromal landscapes. The study included lung tissue samples from 12 COVID-19 patients and 12 patients with undifferentiated community-acquired pneumonia (CAP). Histochemical, monoplex, and multiplex immunohistochemical staining with spatial phenotyping, profiling, and mapping of MCs, as well as interactions with the immune and stromal landscape of the lungs, including elastic and collagen fibers, were used. Compared with other respiratory infections, SARS-CoV-2-associated pneumonia caused an increase in the pool of MCs in the lungs simultaneously with the activation of targeted secretion of tryptase and the formation of significant differences in the spatial phenotype of colocalization of MCs with immunocompetent cells and fibers. The intensity of juxtacrine and paracrine interactions of MC with cytotoxic lymphocytes and monocytes increased, initiating the polarization of macrophages into type 2. In this case, MCs and type 2 macrophages formed extended multicellular chains in the form of a functional syncytium, creating profibrotic niches of the local tissue microenvironment. Under COVID-19 conditions, an unexpected increase in MC interaction with elastic extracellular matrix (ECM) fibers and localized tryptase release revealed new insights into tissue tensometry and ECM remodeling. New spatial patterns of interaction between MCs and the immune and stromal landscape may have beneficial effects in developing therapeutic solutions for fibrotic change prevention.

Indexed as

COVID-19LungMast CellsAgedCommunity-Acquired PneumoniaExtracellular MatrixFemaleHumansMacrophagesMaleMiddle AgedSARS-CoV-2Stromal CellsTryptasesTryptasesCollagenCOVID-19ECMElastic fibersFibrosisImmune landscapeMast cellsSpatial phenotypingTryptase

Identifiers

PMID42173910
PMCPMC13402686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.